Literature DB >> 14625783

Combined treatment of radiofrequency ablation and acetic acid injection: an in vivo feasibility study in rabbit liver.

Jeong Min Lee1, Young Hwan Lee, Young Kon Kim, Sang Won Kim, Se Hyung Kim, Joon Koo Han, Byung Ihn Choi.   

Abstract

The aim of this study was to compare the effects of percutaneous radiofrequency ablation (RFA) combined with percutaneous acetic acid injection (PAI) and either therapy alone for their effects on in vivo rabbit liver tissue. Thirty New Zealand white rabbits were included in this study and were allocated to three groups: group A, conventional RFA (n = 10); group B, PAI (n = 10); and group C, combined RFA and PAI (n = 10). Under US guidance, 1 ml of 50% acetic acid was injected into the target area of the liver parenchyma through a 21-G Chiba needle before performing RFA. The RFA was then performed using a 17-G internally cooled electrode with 1-cm active tip, and RF energy (30 W) was applied for 3 min with or without acetic acid injection. After RFA or PAI, contrast-enhanced CT and CT pathologic correlation were performed. The maximum diameters of the thermal lesions in each group were compared. All procedures were technically successful, and a total of 30 lesions (10 lesions for each group) were produced. The mean maximum diameter of the coagulation necrosis in the rabbits of group C (25+/-9 mm) was significantly larger than the diameters of the other groups: 12.2 +/- 1 mm (group A) and 14.3 +/- 3 mm (group B; p = 0.001). On contrast-enhanced CT scanning, the lesions of group B (7 of 10, 70%) appeared frequently irregular compared with those of groups A (2 of 10, 20%) and C (4 of 10, 40%; p = 0.08). There were seven complications (23.3%): a localized hematoma in a group-A rabbit; two hematomas and one chemical peritonitis in group-B rabbits; and a hematoma, a chemical peritonitis, and a burn injury to the stomach in group-C rabbits. Compared with the group-A rabbits (1 of 10, 10%), the group-B (3 of 10, 30%) and group-C rabbits (3 of 10, 30%) showed a tendency toward complications, but the difference was not significant (p = 0.48). Under the present experimental condition, combined RFA and PAI was able to increase the diameter of coagulation necrosis up to 2.5 cm without significantly increasing complications. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625783     DOI: 10.1007/s00330-003-2140-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

Review 1.  Radiofrequency ablation of the liver: current status.

Authors:  J P McGhana; G D Dodd
Journal:  AJR Am J Roentgenol       Date:  2001-01       Impact factor: 3.959

2.  A novel "cooled-wet" electrode for radiofrequency ablation.

Authors:  Y Ni; Y Miao; S Mulier; J Yu; A L Baert; G Marchal
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

3.  A comparative study on validation of a novel cooled-wet electrode for radiofrequency liver ablation.

Authors:  Y Miao; Y Ni; J Yu; G Marchal
Journal:  Invest Radiol       Date:  2000-07       Impact factor: 6.016

4.  Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results.

Authors:  L Buscarini; E Buscarini; M Di Stasi; D Vallisa; P Quaretti; A Rocca
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

5.  Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model.

Authors:  S N Goldberg; P F Saldinger; G S Gazelle; J C Huertas; K E Stuart; T Jacobs; J B Kruskal
Journal:  Radiology       Date:  2001-08       Impact factor: 11.105

6.  Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy.

Authors:  N Honda; Q Guo; H Uchida; H Ohishi; Y Hiasa
Journal:  Radiology       Date:  1994-01       Impact factor: 11.105

7.  Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

Authors:  T Livraghi; S N Goldberg; S Lazzaroni; F Meloni; T Ierace; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

Review 8.  Radiofrequency thermal ablation of hepatocellular carcinomas.

Authors:  H K Lim
Journal:  Korean J Radiol       Date:  2000 Oct-Dec       Impact factor: 3.500

9.  Radio-frequency tissue ablation: effect of pharmacologic modulation of blood flow on coagulation diameter.

Authors:  S N Goldberg; P F Hahn; E F Halpern; R M Fogle; G S Gazelle
Journal:  Radiology       Date:  1998-12       Impact factor: 11.105

10.  Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

Authors:  T Livraghi; A Giorgio; G Marin; A Salmi; I de Sio; L Bolondi; M Pompili; F Brunello; S Lazzaroni; G Torzilli
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

View more
  3 in total

1.  Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model.

Authors:  A Maataoui; J Qian; D Vossoughi; M F Khan; E Oppermann; W O Bechstein; T J Vogl
Journal:  Eur Radiol       Date:  2004-12-04       Impact factor: 5.315

2.  Trans-arterial gene therapy for hepatocellular carcinoma in a rabbit model.

Authors:  Tao Gu; Cai-Xia Li; Yan Feng; Qian Wang; Chun-Hai Li; Chuan-Fu Li
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

3.  Combined radiofrequency ablation and acetic acid hypertonic saline solution instillation: an in vivo study of rabbit liver.

Authors:  Jeong Min Lee; Young Kon Kim; Sang Won Kim; Joon Koo Han; Se Hyung Kim; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2004 Jan-Mar       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.